Does brachytherapy boost improve survival outcomes in Gleason Grade Group 5 patients treated with external beam radiotherapy and androgen deprivation therapy? A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Does brachytherapy boost improve survival outcomes in Gleason Grade Group 5 patients treated with external beam radiotherapy and androgen deprivation therapy? A systematic review and meta-analysis

Published:2023-01 Issue: Volume:38 Page:21-27
ISSN:2405-6308
Container-title:Clinical and Translational Radiation Oncology
language:en
Short-container-title:Clinical and Translational Radiation Oncology

Author:

Tang Terence,Gulstene Stephanie,McArthur Eric,Warner Andrew,Boldt Gabriel,Velker Vikram,D'Souza David,Bauman Glenn,Mendez Lucas C.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference49 articles.

1. Time trends and local variation in primary treatment of localized prostate cancer;Cooperberg;J Clin Oncol,2010

2. High-risk prostate cancer-classification and therapy;Chang;Nat Rev Clin Oncol,2014

3. Aslam N, Nadeem K, Noreen R JAC. Prostate Cancer Prostate Cancer. Abeloff’s Clin Oncol 5/E 2015;8:938–44.

4. A contemporary prostate cancer grading system: A validated alternative to the Gleason score;Epstein;Eur Urol,2016

5. Integrative clinical genomics of advanced prostate cancer;Robinson;Cell,2015

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brachytherapy for high grade prostate cancer induces distinct changes in circulating CD4 and CD8 T cells – Implications for systemic control;Radiotherapy and Oncology;2024-02

2. Is Ultrahypofractionated Whole Pelvis Radiation Therapy (WPRT) as Well Tolerated as Conventionally Fractionated WPRT in Patients With Prostate Cancer? Early Results From the HOPE Trial;International Journal of Radiation Oncology*Biology*Physics;2023-12